Analysis

Inovio Pharmaceuticals shares edged higher in early trading, gaining 1.48% to reach $2.75. This modest uptick follows the company's participation...

An intriguing divergence defines Anterix's current market narrative. The telecommunications specialist presents a paradox of formidable financial health set against...

All eyes are on Oracle this week as the technology giant prepares to report quarterly earnings that will serve as...

James Hardie Industries shares continue to experience significant downward momentum in trading. The building materials manufacturer has been on a...

While Zevra Therapeutics recently announced encouraging clinical results for its lead drug candidate, MIPLYFFA, its stock performance tells a contrasting...

A familiar name in the automotive supply chain, American Axle & Manufacturing, is attracting significant attention from major financial institutions....

Shares of water infrastructure company Cadiz saw a modest uptick on Thursday, advancing 1.13 percent to close at $3.58. This...

Lyell Immunopharma has initiated a pivotal Phase 3 clinical trial for its lead CAR T-cell therapy, marking a significant strategic...

Investors in Selectquote face a critical October 10th deadline to join ongoing securities fraud class action lawsuits against the company....

QuinStreet Inc. finds itself at a pivotal juncture as its leadership prepares to address the investment community. The company's management...